dioxadet has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrov, VA; Aristova, VA; Beliaev, AM; Beliaeva, OA; Bespalov, VG; Ivantsov, AO; Kireeva, GS; Maĭdin, MA; Semënov, AL; Senchik, KIu; Stukov, AN; Vyshinskaia, EA | 1 |
| Alexeev, VV; Belyaev, AM; Belyaeva, OA; Bespalov, VG; Gafton, GI; Guseinov, KD; Kireeva, GS; Senchik, KY; Soloviev, LA; Stukov, AN; Vasilchenko, MV | 1 |
2 other study(ies) available for dioxadet and Carcinoma, Anaplastic
| Article | Year |
|---|---|
[Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
Topics: Abdominal Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Hyperthermia, Induced; Neoplasms, Experimental; Ovarian Neoplasms; Pelvis; Rats; Rats, Wistar; Triazines | 2014 |
[Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Hyperthermia, Induced; Intraoperative Period; Ovarian Neoplasms; Peritoneal Cavity; Peritoneal Neoplasms; Rats; Rats, Wistar; Survival Analysis; Triazines | 2015 |